Testosterone Cypionate: The Complete Guide

Your doctor said your testosterone was "normal." But you feel terrible. You're exhausted, you've gained weight around the middle, your gym performance has slipped, and your drive (for work, for sex, for pretty much everything) has quietly left the building.

So you did what any reasonable person does. You went to Reddit. You watched YouTube. You found terms like "test cyp" and "TRT protocol" and "twice-weekly injections." And now you want the real explanation, not the three paragraphs most doctors manage to say before reaching for the door handle.

Testosterone cypionate is the most widely prescribed injectable testosterone in the United States. It's FDA-approved, it's been studied in clinical trials for decades, and when done right under physician supervision, it's one of the most effective tools in men's hormone optimization. This guide covers everything: how it works, how it's dosed, how to inject it properly, what labs to monitor, what to watch out for, and how much it actually costs.

---

What Is Testosterone Cypionate?

Testosterone cypionate is an injectable form of testosterone attached to a cypionate ester, which controls how slowly the hormone releases into your bloodstream after injection. Marketed as Depo-Testosterone (Pfizer) and available as generic formulations from multiple manufacturers, it's a Schedule III controlled substance and requires a prescription in the United States.

The FDA approved testosterone cypionate for the treatment of male hypogonadism (the clinical term for low testosterone caused by testicular failure, pituitary problems, or other medical conditions). It's available as a 200 mg/mL oil-based solution, typically in cottonseed oil with benzyl benzoate and benzyl alcohol as a preservative.

What makes cypionate useful is the ester chain. That cypionate group buys you time. Instead of testosterone disappearing from your system within hours (as with non-esterified testosterone), the ester slows absorption from the injection site and gives you a sustained release profile that lasts days to weeks.

Testosterone cypionate is not a gray-market compound, a peptide, or an unapproved experimental drug. It's a generic pharmaceutical with 43 FDA-label registrations in the openFDA database and 8,501 adverse event reports in the FAERS system. That's the footprint of decades of legitimate clinical use.

---

How Testosterone Cypionate Works: The Pharmacokinetics

Understanding how this drug behaves in your body makes every other decision make a lot more sense: how often to inject, how much to use, when to check labs.

Testosterone cypionate has a half-life of approximately 8 days when injected intramuscularly (per the FDA prescribing information, Depo-Testosterone label). This means that 8 days after a single injection, roughly half the dose remains active in your system. After another 8 days, half of that remains. It takes 4-5 half-lives (about 5-6 weeks) to reach steady-state blood levels.

Here's what that looks like in practice: if you inject 100 mg every 7 days, your testosterone levels will peak 1-2 days after injection, then gradually decline toward your next injection. After 5-6 weeks of consistent injections at the same dose and frequency, your trough-to-peak variation stabilizes. That stabilization point is what your physician is targeting when they look at your labs.

The ester hydrolysis process is exactly what it sounds like: enzymes in your blood cleave the cypionate chain off the testosterone molecule, releasing free testosterone. The release isn't instant. It happens gradually from the depot at the injection site. This is why testosterone cypionate doesn't spike dramatically on day one the way a water-based testosterone suspension would.

About 98% of testosterone in your plasma is bound. Roughly half goes to sex hormone-binding globulin (SHBG) and most of the rest to albumin. Only the remaining 2% circulates as free testosterone (per the FDA clinical pharmacology section). Free testosterone is what actually gets into cells and drives the effects you're looking for. This matters for your labs: total testosterone alone doesn't tell the whole story.

Testosterone is metabolized primarily in the liver. About 90% of a dose is excreted in urine as glucuronic and sulfuric acid conjugates; roughly 6% exits in feces. Before excretion, testosterone converts to dihydrotestosterone (DHT) and estradiol (E2) through enzymatic activity. The estradiol conversion is what drives estrogen-related side effects at higher doses, which we'll cover in the monitoring section.

---

Testosterone Cypionate Dosage: What the Research Says

The FDA prescribing information for testosterone cypionate lists an approved dosing range of 50 to 400 mg every 2 to 4 weeks for hypogonadism. In clinical practice, physicians typically work in a narrower therapeutic window.

Standard TRT dosing in clinical practice: 50 to 200 mg per week, often split into twice-weekly injections.

What does the clinical evidence show?

In a randomized controlled trial by Sih et al. (1997), 17 hypogonadal men received 200 mg testosterone cypionate biweekly for 12 months. The results: improved bilateral grip strength (p < 0.05), increased hemoglobin (p < 0.001), and reduced leptin levels. Three participants withdrew due to hematocrit elevation, which is exactly why monitoring is non-negotiable (Sih et al., 1997).

A trial by Perry et al. (2002) compared 100 mg/week versus 200 mg/week in 16 elderly depressed men. Mean Hamilton Depression Rating Scale scores dropped 42% across the group, with the strongest responses in men with late-onset depression. Both doses suppressed LH and FSH (the pituitary signals that tell your testes to produce testosterone naturally) (Perry et al., 2002).

MacIndoe et al. (1997) confirmed that even at 100 mg/week, LH and FSH become undetectable within 5-6 weeks. Spermatogenesis was impaired at all doses tested (100, 250, and 500 mg/week). If fertility matters to you, this conversation needs to happen with your physician before you start.

The practical takeaway: there's no universal "correct" dose. Your physician starts with labs, not with a number they read somewhere. Total testosterone, free testosterone, SHBG, and estradiol all factor into where you start and how you titrate.

---

Once Weekly vs. Twice Weekly: The Frequency Debate

This is one of the most common questions in TRT communities, and it has a real answer grounded in pharmacokinetics.

Once weekly gives you a larger trough-to-peak swing. Peak testosterone (usually 24-48 hours post-injection) will be meaningfully higher than trough (day 6-7 pre-injection). Some men handle this well. Others notice symptom variations across the week: more energy and libido early, sluggishness or mood dips by day 6.

Twice weekly flattens that curve. Smaller injections (half the weekly dose given on, say, Monday and Thursday) produce more stable blood levels throughout the week. This also means lower estradiol spikes, since the aromatization that converts testosterone to estrogen tracks with testosterone peak levels.

From a clinical standpoint, twice-weekly injections produce more physiologically consistent testosterone and estradiol levels, which generally translates to fewer symptoms from hormone fluctuation. Many TRT physicians use this as their default protocol for this reason.

For men who find needle frequency burdensome, or who have genuinely stable levels on once-weekly dosing without symptom cycling, once-weekly is reasonable. The decision is individual. Your labs at trough (day 6-7 for weekly, day 3-4 for twice-weekly) will tell you whether your protocol needs adjustment.

Sub-Q (subcutaneous) injection at smaller volumes makes twice-weekly or even every-other-day dosing more practical. More on injection technique below.

---

Test Cyp vs. Enanthate: Is There an Actual Difference?

Testosterone enanthate and testosterone cypionate are functionally nearly identical. Both are oil-soluble testosterone esters. Both require injection. Both produce similar pharmacokinetic profiles at equivalent doses.

The pharmacological differences are minimal:

• Half-life: Enanthate is approximately 4-5 days; cypionate is approximately 8 days. In practice, both support weekly or twice-weekly injection schedules without meaningful clinical difference.
• Ester carbon chain: Enanthate has 7 carbons; cypionate has 8. This makes cypionate very slightly heavier per mg of preparation, meaning a 100 mg dose of cypionate contains marginally less actual testosterone by mass. The difference is small enough to be clinically irrelevant at standard doses.
• Carrier oil: Most cypionate formulations use cottonseed oil; enanthate is often suspended in sesame or castor oil. For men with cottonseed allergies, enanthate may be preferable.

A 1980 comparison by Schulte-Beerbühl and Nieschlag directly compared testosterone serum levels after injections of enanthate versus cypionate. Testosterone, DHT, LH, and FSH levels were not significantly different between the two preparations (Schulte-Beerbühl and Nieschlag, 1980).

In the United States, cypionate dominates TRT prescribing. Enanthate is more commonly used in Europe. If you're traveling or your pharmacy runs out of one, the other is a drop-in substitute at the same dose and frequency.

The meaningful difference between TRT formulations isn't cypionate versus enanthate. It's injectable oil versus topical gel versus pellets. That's a real delivery method decision with different bioavailability profiles, compliance patterns, and cost structures. If you want a deeper breakdown, see our guide to TRT delivery methods.

---

Injection Technique: How to Do This Right

Injection technique is where most preventable problems happen. The community Reddit post that went viral (the guy given 14-gauge needles by his pharmacy for testosterone cypionate) is a real example of how bad information from well-meaning but undertrained providers can make this experience miserable before it starts.

Needle Selection

For intramuscular (IM) injection:

• Draw the medication with a 21-23 gauge, 1.5-inch needle (larger gauge draws faster)
• Switch to a 23-25 gauge, 1-inch needle for the actual injection
• Never inject with the draw needle. Drawing creates a small burr on the tip that makes the injection more painful

For subcutaneous (SC) injection:

• 27-29 gauge, 0.5-inch insulin-style needle
• Pinch 1-2 inches of subcutaneous tissue and inject at 45-90 degrees

A study by Spratt et al. (2017) followed 63 patients receiving subcutaneous testosterone cypionate or enanthate weekly at doses of 50-150 mg. All patients achieved testosterone levels within the normal male range; minor local reactions occurred in 9 of 63 patients. Twenty-two patients who switched from IM to SC reported preference for the SC route (Spratt et al., 2017).

Injection Sites

Glute (ventrogluteal or dorsogluteal): The traditional IM site. The ventrogluteal site (hip, slightly forward from the glute) is safer than the dorsogluteal (upper outer buttock) because it avoids the sciatic nerve and superior gluteal artery. Rotation across quadrants prevents scar tissue buildup.

Vastus lateralis (outer thigh): A practical self-injection site for IM. Locate the middle third of the outer thigh, avoid the inner surface and the front.

Deltoid (shoulder): Suitable for small volumes (up to 1 mL). Not recommended for larger weekly volumes due to muscle mass limitations.

Subcutaneous abdomen or thigh: For SC injection, the pinchable fat of the lower abdomen or outer thigh works well. Rotate sites to prevent lipohypertrophy (localized fat buildup from repeated injections).

Injection Rotation

Rotate among multiple sites. Injecting into the same spot repeatedly causes post-injection pain, scar tissue, and eventually poor absorption from fibrotic tissue. A simple rotation schedule (left glute, right glute, left thigh, right thigh, then repeat) prevents this.

Aspiration Debate

Current evidence and most physician guidance no longer recommends aspiration (pulling back the plunger to check for blood) before injecting into muscle. The risk of inadvertent intravenous injection from IM injection into standard TRT sites is extremely low, and aspiration causes additional tissue trauma. Your HEXIS provider will walk you through the current protocol for your specific injection site.

---

Lab Monitoring: What to Track and When

Starting TRT without monitoring labs is not optimization. It's guesswork. Here's what you need to track and why.

The Core Panel

Total testosterone (trough): Draw your blood at trough (the low point before your next injection). For weekly injections, that's day 6-7. For twice-weekly, that's day 3 before your next dose. Trough total T should typically fall between 500-1000 ng/dL for most TRT patients, though this varies by individual response and symptom profile.

Free testosterone: Total T alone can mislead you. A man with high SHBG might have total T of 700 ng/dL with free T in the tank. Ask specifically for free testosterone, calculated or dialysis-measured. For reference, calculated free testosterone below 15 ng/dL is often where symptoms appear despite acceptable total T.

SHBG (Sex Hormone-Binding Globulin): SHBG determines how much of your total testosterone is actually bioavailable. High SHBG (common in older men and with certain medications) means more of your total T is bound and inactive. Low SHBG means more free T but faster clearance. Your protocol may need adjustment based on your SHBG.

Estradiol (sensitive assay): Use the LC/MS estradiol assay, not the standard immunoassay. The immunoassay was designed for female reference ranges and can read falsely in men on TRT. Estradiol in the 20-40 pg/mL range is generally well-tolerated for most men; problems with water retention, mood changes, or libido issues often appear at extremes in either direction.

Hematocrit: Testosterone stimulates erythropoietin production, which increases red blood cell mass. Hematocrit above 52-54% increases blood viscosity and raises cardiovascular risk. This is one of the most clinically significant monitoring values on TRT. If hematocrit rises, your physician may reduce dose, increase injection frequency (which blunts erythropoietic stimulus), or recommend therapeutic phlebotomy.

PSA (Prostate-Specific Antigen): Required baseline for men over 40. TRT does not cause prostate cancer, but it can accelerate existing sub-clinical disease. PSA doubling or a rise above 1.4 ng/mL over 12 months warrants urological evaluation (per Endocrine Society guidelines).

LH and FSH: These drop to near-zero on TRT as your pituitary detects adequate testosterone and stops stimulating the testes. Useful for confirming suppression and, if you ever need to restart natural production, baseline reference.

Monitoring Schedule

• Baseline: before first injection
• 6-8 weeks: first follow-up (steady-state has been reached)
• 3 months: second check, after any dose adjustments
• Every 6-12 months: maintenance monitoring

If you're through a telehealth TRT provider, confirm they're checking all of the above, not just total testosterone. Monitoring only total T is the most common shortcut that leads to avoidable problems.

For a step-by-step guide to understanding your hormone panel, see our article on how to test testosterone levels.

---

Testosterone Cypionate Side Effects and Safety

8,501 adverse event reports in the FDA FAERS database represents real clinical use at scale. That number isn't scary. It's context. A medication with zero adverse event reports hasn't been used widely. The question is what those reports tell us and how to minimize risk.

Common Side Effects

Erythrocytosis (elevated hematocrit): The most clinically significant side effect with injectable testosterone. Monitor hematocrit at each follow-up. If it climbs above 52%, dose reduction or therapeutic phlebotomy is standard management.

Injection site reactions: Mild pain, redness, and swelling at the injection site are common, especially when starting. These typically improve with technique refinement (sharper needles, proper site rotation, warming the oil slightly).

Acne and oily skin: Driven by DHT conversion from testosterone. More common at higher doses. Topical or oral treatments can manage this; dose optimization is the primary lever.

Testicular atrophy: With exogenous testosterone suppressing LH and FSH, the testes reduce production. Some men on TRT add human chorionic gonadotropin (hCG) to maintain testicular size and function. This is a conversation worth having with your provider, especially if fertility is a concern.

Mood variability: This typically tracks with testosterone fluctuations. Large trough-to-peak swings (common with infrequent dosing) can produce irritability near trough and elevated mood at peak. Splitting doses reduces this.

Cardiovascular Safety: The TRAVERSE Trial

The TRAVERSE trial (Lincoff et al., 2023) was a landmark cardiovascular outcomes study in men with hypogonadism and high cardiovascular risk. Over a median follow-up of 33 months, testosterone replacement was non-inferior to placebo for major adverse cardiovascular events. This is the largest and most rigorous cardiovascular safety data on TRT to date, and it significantly informed the FDA's 2024 labeling updates.

The nuance: testosterone did increase incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism compared to placebo in TRAVERSE. These are real findings that warrant appropriate patient selection and monitoring, not dismissal.

The Supraphysiologic Dose Picture

The mood and aggression data from the research literature comes almost entirely from supraphysiologic doses, well above TRT levels.

Pope et al. (2000) administered testosterone cypionate in doses rising to 600 mg/week to 56 men in a randomized, placebo-controlled, crossover trial. At these doses, significantly elevated manic scores occurred. But the distribution mattered: 84% of men who received 600 mg/week showed minimal psychiatric effects; only 4% became markedly hypomanic. Physiologic TRT doses (100-200 mg/week) weren't associated with these effects (Pope et al., 2000).

Kouri et al. (1995) demonstrated increased aggressive responding at doses of 150-600 mg/week in a laboratory setting. Again, these are doses 3-10x typical TRT prescriptions (Kouri et al., 1995).

Yates et al. (1999) found that doses up to 500 mg/week "appear to have minimal risk of adverse psychosexual effects in the majority of normal men" in a randomized, double-blind dose-comparison trial (Yates et al., 1999).

The bottom line: TRT at physiologic replacement doses carries a different safety profile than the supraphysiologic doses used in bodybuilding. Conflating the two is one of the most common errors in how this topic gets discussed.

---

What TRT Actually Does: The Clinical Evidence

Men don't start TRT because they read about pharmacokinetics. They start because they feel bad and want to feel better. Here's what the evidence shows about outcomes at physiologic doses.

Grip strength and physical function: Sih et al. (1997) showed statistically significant improvements in bilateral grip strength after 12 months of 200 mg biweekly testosterone cypionate in older hypogonadal men. Hemoglobin also improved, which partially explains the energy gains men report.

Mood and depression: Seidman et al. (2009) conducted a six-week double-blind, placebo-controlled trial in 23 men with dysthymia and low-normal testosterone (total T below 350 ng/dL). The mean Hamilton Depression Rating Scale score decreased significantly more in the testosterone group than placebo (7.46 vs. 1.8 points, p = 0.006). Remission occurred in 53.8% of the testosterone group versus 10% of the placebo group (Seidman et al., 2009).

Fatigue and energy: Rabkin et al. (2004) compared testosterone (up to 400 mg biweekly) versus fluoxetine versus placebo in a trial of 123 HIV-positive men with depression and fatigue. Testosterone was superior to both fluoxetine and placebo for fatigue outcomes among completers (Rabkin et al., 2004).

Sexual function: Rhoden and Morgentaler (2010) reviewed 127 consecutive men treated with injectable testosterone (enanthate or cypionate) or transdermal gel. By 3 months, 70% reported improvements in erections, libido, energy, or mood. Sixty-three percent remained on therapy at 12 months with subjective benefit (Rhoden and Morgentaler, 2010).

Nocturnal penile tumescence: Cunningham et al. (1990) demonstrated that testosterone cypionate directly and rapidly affects erectile function. In six hypogonadal men, significant declines in NPT episodes, penile circumference increase, and tumescence time occurred when testosterone dropped, and improved with restoration (Cunningham et al., 1990). If you've wondered about the connection between testosterone and erectile function, this is it.

---

Cost, Insurance, and Access

This is the section that most testosterone cypionate guides skip. Don't go into a TRT consultation without understanding what you're actually going to pay.

Generic Testosterone Cypionate

Generic testosterone cypionate is one of the least expensive injectable drugs in the United States. With GoodRx or discount card pricing, a 10 mL vial (200 mg/mL, enough for several months at typical TRT doses) typically runs $30-80 out of pocket depending on pharmacy and location. Some community pharmacies offer it for less.

Brand Name (Depo-Testosterone, Pfizer)

Depo-Testosterone brand costs significantly more, typically $100-300 per vial without insurance. There is no clinical reason to use brand over generic for most patients. The formulation is identical.

Compounded Testosterone Cypionate

Compounding pharmacies can prepare testosterone cypionate in different concentrations (40 mg/mL for SC injection, which reduces injection volume) or with alternative carrier oils (sesame oil for cottonseed-sensitive patients). Compounded formulations typically run $30-60/month depending on the compounding pharmacy and volume. HEXIS works with licensed compounding pharmacies for patients whose needs aren't met by commercial preparations.

Insurance Coverage

Most major insurance plans cover testosterone cypionate for hypogonadism when the diagnosis is properly documented (typically requiring two morning testosterone draws below the lab's reference range with consistent symptoms). Coverage varies significantly by plan; some require prior authorization. A GoodRx discount can sometimes beat insurance copays for generics.

Telehealth TRT programs like HEXIS typically bundle physician visits, lab monitoring, and access to medication through their pharmacy networks. This model works well for men who don't want to navigate insurance prior authorization or who prefer physician-level care without the in-office wait.

---

How to Get Started on Testosterone Cypionate

If you're reading this and thinking "this might apply to me," the next step isn't ordering anything online. It's labs.

At HEXIS, your testosterone cypionate protocol starts with a full hormone panel: total testosterone, free testosterone, SHBG, estradiol (sensitive), hematocrit, PSA (if over 40), LH, FSH, and basic metabolic markers. Your HEXIS provider reviews those labs, your symptoms, and your goals before recommending any protocol.

If you're in Great Falls, MT, you can schedule an in-person consultation. If you're in Montana, Washington, Idaho, or Oregon, telehealth works the same way: labs, consult, physician-supervised protocol, follow-up monitoring.

You can also learn more about the broader testosterone replacement therapy complete guide and what to expect from your first TRT evaluation.

Your protocol starts with labs, not guesswork. Schedule a consultation to get started.

---

Frequently Asked Questions

What is the standard testosterone cypionate dosage for TRT?

The FDA-approved dosing range is 50-400 mg every 2-4 weeks, but standard TRT practice uses 50-200 mg per week, often split into twice-weekly injections. Your physician determines the appropriate dose based on lab results, symptoms, and response to initial treatment. There is no universal starting dose.

How long does it take for testosterone cypionate to work?

Most men notice improvements in energy and sleep quality within 3-6 weeks. Libido and mood changes typically follow by weeks 4-8. Body composition improvements (reduced fat mass, increased lean mass) develop over 3-6 months of consistent treatment. Full clinical response assessment is generally done at the 3-month mark.

Does testosterone cypionate need to be refrigerated?

No. Testosterone cypionate in oil suspension is stable at room temperature (below 30°C / 86°F). Avoid excessive heat and direct sunlight. Cold temperatures can thicken the oil, making it harder to draw. Warming the vial briefly in your hands before drawing is fine.

What needle size should I use for testosterone cypionate injection?

For intramuscular injection: draw with a 21-23 gauge needle, then switch to a 23-25 gauge, 1-inch needle for the actual injection. For subcutaneous injection: 27-29 gauge, 0.5-inch needle. The 14-gauge needles sometimes prescribed by uninformed providers are completely inappropriate and unnecessarily painful.

Can women use testosterone cypionate?

Yes. Testosterone is an important hormone for women as well, involved in libido, energy, and body composition. Women typically use much lower doses (10-25 mg/week or less). Testosterone cypionate is sometimes prescribed off-label for women with documented testosterone deficiency. Monitoring and dose calibration are even more important in women given the narrower therapeutic window.

---